ROBERT PLATZMAN: Open Payments
NPI 1497852966 · PRINCETON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$775 in 42 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $369 · 2025 $775
Food & beverage: $775
| Company | Payments | Amount |
|---|---|---|
| Alpha Cognition USA, Inc. | 2 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $88 |
| Eisai Inc. | 4 | $63 |
| Amgen Inc. | 4 | $62 |
| PFIZER INC. | 4 | $59 |
| Lilly USA, LLC | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| ACADIA Pharmaceuticals Inc | 3 | $49 |
| Exact Sciences Corporation | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
Products named: Zunveyl, Kerendia, REXULTI, Leqembi, OTEZLA, CAPLYTA, NUPLAZID, Cologuard Collection Kit.
Industry payments across NJ — which companies pay providers there.
